Abstracts tagged "Assessment and vasculitis"

Abstract Number: 874 • 2015 ACR/ARHP Annual Meeting
The Short Term Damage Burden in Vasculitis and Vasculitis Mimics As Measured By the Vasculitis Damage Index
Alberto Floris^1,2, Jan Sznajd^3,4, Katarzyna Wawrzycka-Adamczyk^1,5, Joanna Robson⁶, Anthea Craven⁷, Peter A. Merkel⁸, Richard A. Watts⁹, Raashid Luqmani³ and DCVAS investigators, ¹Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, ²Rheumatology Unit, University Clinic, Cagliari, Italy, Monserrato, Italy, ³Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, ⁴Jagiellonian University Medical College, Kraków, Poland, ⁵Jagiellonian University Medical College, Cracow, Poland, ⁶Rheumatology, University of Oxford, Oxford, United Kingdom, ⁷Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, ⁸Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ⁹Rheumatology Department Ipswich Hospital, University of East Anglia, Ipswich, United Kingdom
Background/Purpose: Damage in vasculitis, which is due to both the vasculitic process itself and the complications of treatment, accumulates over time and accounts for significant…
Abstract Number: 875 • 2015 ACR/ARHP Annual Meeting
Differences in Early Damage Patterns in Various Forms of Primary Systemic Vasculitis
Katarzyna Wawrzycka-Adamczyk^1,2, Joanna Robson³, Alberto Floris^1,4, Jan Sznajd^2,5, Anthea Craven⁶, Richard A. Watts⁷, Peter A. Merkel⁸, Raashid Luqmani⁵ and DCVAS investigators, ¹Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, ²Jagiellonian University Medical College, Kraków, Poland, ³Rheumatology, University of Oxford, Oxford, United Kingdom, ⁴Rheumatology Unit, University Clinic, Cagliari, Italy, Monserrato, Italy, ⁵Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, ⁶Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, ⁷Rheumatology Department Ipswich Hospital and University of East Anglia, Ipswich, United Kingdom, ⁸Division of Rheumatology, University of Pennsylvania, Philadelphia, PA
Background/Purpose: Immunosuppressive agents have changed the outcome of the systemic vasculitides from invariably fatal to chronic conditions associated with damage as a result of disease,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].